MedTrace Logo

Superficial Cervical Plexus Block for Pacemaker Insertion

NCT01473667 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-02-01

No results posted yet for this study

Summary

The purpose of this study is to investigate clinical outcomes from two current standard of care pain control procedures performed for patients undergoing pacemaker insertion.

Conditions

  • Pacemaker Insertion
  • Regional Block
  • Pain

Interventions

PROCEDURE

Superficial Cervical Plexus Block (SCP) block

SCP block using 10-15ml of 1% Ropivacaine

PROCEDURE

Local site infiltration

Local site infiltration using 2% lidocaine

Sponsors & Collaborators

Principal Investigators

  • Christopher Robards, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2015-03-31
Completion
2016-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01473667 on ClinicalTrials.gov